Skip to main content
OpenTrials
Completed

NCT Number: NCT04717076

PrevA Study - Evaluation of an App-based Nutritional Concept

The PrevA study is designed to evaluate our developed nutritional concept to implement a heart healthy diet. The nutritional concept based on nutrient-optimized daily menu plans for each study day. The plans are personalized according to participants age, gender, and level of physical activity. The PrevA study consists of four periods differing in the energy intake specified by the menu plans.

The study is carried out in a 4-armed parallel design. In group 1, the participants receive the individualized daily plans via the app coupled with the smartwatch to record participants physical activity and heart rate. Groups 2 and 3 receive a printed version of the daily plans with or without personal nutritional advice. The fourth group serves as a control group, which receives general nutritional recommendations but no daily menu plans. During this time, blood samples and urine are collected every four weeks to analyze the study parameters.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–69 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Friedrich-Schiller University

Jena, Thuringia, 07743, Germany

About this study

Smartphone-based communication technologies are developing rapidly, and the number of so-called mobile health applications is rising. The number of validated and scientifically tested offers is comparatively small. To address this weak point, we developed a personalized nutritional concept to implement a heart-healthy diet. In cooperation with the Preventicus GmbH, Jena, the concept was integrated in an App-based tool. In addition, the app relates to a smartwatch to encourage and track physical activity. The PrevA study will be conducted to evaluate the overall concept.

The nutritional concept based on nutrient-optimized daily menu plans for each study day. The plans are personalized according to participants age, gender, and level of physical activity.

The study is carried out in a 4-armed parallel design. In group 1, the participants receive the individualized daily plans via the app coupled with the smartwatch to record participants physical activity and heart rate. Groups 2 and 3 receive a printed version of the daily plans with or without personal nutritional advice. The fourth group serves as a control group, which receives general nutritional recommendations but no daily menu plans.

In groups 1 to 3, the daily plans are issued in 4 energy levels. At the beginning, the test subjects receive daily plans according to the recommendations for energy intake of the German Nutrition Society (DGE), adapted to their age, gender, and activity level (level 1). After four study weeks, the energy content of the plans is reduced to 85% of the energy intake recommended by the DGE (level 2) and after further four weeks of the PrevA study the energy level is reduced to 70% of the energy intake recommended by the DGE (level 3). Level 4 serves as a stabilization phase and provides the energy content of level 1. The study period extends over a total of 16 study weeks. During this time, blood samples and urine are collected every four weeks to analyze the study parameters. In addition, anthropometric data, data on personal health status and cardiovascular risk profile are assessed.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Voluntary participation with documented informed consent
  • Willingness and ability to adhere to the study protocol
  • Males / female) aged ≥ 20 years and ≤ 51 years
  • BMI: ≥ 25 ≤ 35 kg / m2 (obesity grade 1)
  • Owning a smartphone (android)
  • no or moderate alcohol consumption (≤ 2 glasses / week)
  • non-smoker (if possible)

Exclusion criteria

Comorbidities:

  • Hypercholesterolemia (genetic defect / familial predisposition)
  • Diabetes mellitus type 1 or 2
  • Thyroid dysfunction (hyper- or hypothyroidism)
  • Food intolerance / allergies to ingredients in the study foods
  • Medications: lipid-lowering drugs, glucocorticoids
  • Dietary supplements: especially n-3 fatty acids, vitamin E.
  • Extremely high physical activity (daily)
  • Alcohol abuse (daily)
  • (smoker) [if there are not enough test persons available, > 7 smokers should be included so that a statistical analysis is possible]
  • Uncontrolled organic diseases
  • Alcohol, drug or drug abuse
  • Participation in other clinical observational studies during or 4 weeks. before starting this study
  • Serious behavioral problems, emotional problems or psychiatric problems which the investigator believes would lead to a lack of compliance
  • Pregnancy, breastfeeding and unsafe contraception
  • Other reasons that are considered important by the investigator

Treatment and study plan

App-based nutritional concept and fitness tracking

Behavioral

The App-based nutritional concept based on menu plan, which are personalized according to participants age, gender, physical activity. The App is coupled with a Smartwatch to encourage and track physical activity over the study period.

Nutritional concept with individual nutritional counselling

Behavioral

Nutritional concept based on personalized menu plans and individual nutritional counselling every four weeks (4 times during the study)

Nutritional concept without individual nutritional counselling

Behavioral

Nutritional concept based on personalized menu plans

Primary outcomes

  1. Body weight

    Time frame: change from baseline after 4, 8, 12, 16 weeks

    Body weight (kg)

Secondary outcomes

  1. Body fat

    Time frame: change from baseline after 4, 8, 12, 16 weeks

    Body fat (%)

  2. Systolic blood pressure

    Time frame: change from baseline after 4, 8, 12, 16 weeks

    systolic pressure (mm Hg)

  3. Diastolic blood pressure

    Time frame: change from baseline after 4, 8, 12, 16 weeks

    diastolic blood pressure (mm Hg)

  4. Basal metabolic rate

    Time frame: change from baseline after 4, 8, 12, 16 weeks

    Basal metabolic rate (kcal per day) - measurement: indirect calorimetry

  5. Total cholesterol (plasma)

    Time frame: change from baseline after 4, 8, 12, 16 weeks

    Total cholesterol (mmol/l)

  6. LDL cholesterol (plasma)

    Time frame: change from baseline after 4, 8, 12, 16 weeks

    LDL cholesterol (mmol/l)

  7. HDL cholesterol (plasma)

    Time frame: change from baseline after 4, 8, 12, 16 weeks

    HDL cholesterol (mmol/l)

  8. Triacylglycerides (plasma)

    Time frame: change from baseline after 4, 8, 12, 16 weeks

    Triacylglycerides (mmol/l)

  9. Glucose (fasting) (serum)

    Time frame: change from baseline after 4, 8, 12, 16 weeks

    Glucose (mmol/l)

  10. Insulin (fasting) (serum)

    Time frame: change from baseline after 4, 8, 12, 16 weeks

    Insulin (mU/l)

  11. HbA1c (serum)

    Time frame: change from baseline after 4, 8, 12, 16 weeks

    HbA1c (%)

  12. alpha prothrombin time (serum)

    Time frame: change from baseline after 4, 8, 12, 16 weeks

    alpha prothrombin time (s)

  13. Fibrinogen (serum)

    Time frame: change from baseline after 4, 8, 12, 16 weeks

    Fibrinogen (g/l)

  14. High sensitive c-reactive protein (plasma)

    Time frame: change from baseline after 4, 8, 12, 16 weeks

    High sensitive c-reactive protein (mg/l)

  15. Homocysteine (serum)

    Time frame: change from baseline after 4, 8, 12, 16 weeks

    Homocysteine (µmol/l)

  16. Triiodothyronine (plasma)

    Time frame: change from baseline after 16 weeks

    Triiodothyronine fT3 (pmol/l)

  17. Thyroxine (plasma)

    Time frame: change from baseline after 16 weeks

    Thyroxine fT4 (pmol/l)

  18. Thyroid-stimulating hormone (plasma)

    Time frame: change from baseline after 16 weeks

    Thyroid-stimulating hormone (mU/l)

  19. Parathyroid hormone (plasma)

    Time frame: change from baseline after 16 weeks

    Parathyroid hormone (ng/l)

  20. Alkaline phosphatase (serum)

    Time frame: change from baseline after 16 weeks

    Alkaline phosphatase (µg/l)

  21. Osteocalcin (serum)

    Time frame: change from baseline after 16 weeks

    Osteocalcin (ng/ml)

  22. Uric acid (plasma)

    Time frame: change from baseline after 16 weeks

    Uric acid (µmol/l)

  23. Alanine aminotransferase (plasma)

    Time frame: change from baseline after 4, 8, 12, 16 weeks

    Alanine aminotransferase (µmol/l*s)

  24. Aspartate transaminase (plasma)

    Time frame: change from baseline after 4, 8, 12, 16 weeks

    Aspartate transaminase (µmol/l*s)

  25. Cholinesterase (plasma)

    Time frame: change from baseline after 4, 8, 12, 16 weeks

    Cholinesterase (µmol/l*s)

  26. Gamma-glutamyltransferase (plasma)

    Time frame: change from baseline after 4, 8, 12, 16 weeks

    Gamma-glutamyltransferase (µmol/l*s)

  27. Lactate dehydrogenase (plasma)

    Time frame: change from baseline after 4, 8, 12, 16 weeks

    Lactate dehydrogenase (µmol/l*s)

  28. Fatty acid distribution in plasma lipids (plasma)

    Time frame: change from baseline after 4, 8, 12, 16 weeks

    Fatty acid distribution in plasma lipids (% fatty acid methyl esters)

  29. Fatty acid distribution in erythrocyte lipids (erythrocytes)

    Time frame: change from baseline after 4, 8, 12, 16 weeks

    Fatty acid distribution in erythrocyte lipids (% fatty acid methyl esters)

  30. Vitamin A (serum)

    Time frame: change from baseline after 16 weeks

    Vitamin A (mmol/l)

  31. Vitamin D (plasma)

    Time frame: change from baseline after 16 weeks

    Vitamin D (nmol/l)

  32. Vitamin E (serum)

    Time frame: change from baseline after 16 weeks

    Vitamin E (µmol/l)

  33. Vitamin B1 (serum)

    Time frame: change from baseline after 16 weeks

    Vitamin B1 (nmol/l)

  34. Vitamin B2 (serum)

    Time frame: change from baseline after 16 weeks

    Vitamin B2 (nmol/l)

  35. Vitamin B6 (serum)

    Time frame: change from baseline after 16 weeks

    Vitamin B6 (nmol/l)

  36. Vitamin B12 (plasma)

    Time frame: change from baseline after 16 weeks

    Vitamin B12 (pmol/l)

  37. Holo-transcobalamin (plasma)

    Time frame: change from baseline after 16 weeks

    Holo-transcobalamin (pmol/l)

  38. Folic acid (plasma)

    Time frame: change from baseline after 16 weeks

    Folic acid (µg/l)

  39. Vitamin H (serum)

    Time frame: change from baseline after 16 weeks

    Vitamin H (ng/l)

  40. Vitamin C (plasma)

    Time frame: change from baseline after 16 weeks

    Vitamin C (mg/l)

  41. Calcium (plasma)

    Time frame: change from baseline after 16 weeks

    Calcium (mmol/l)

  42. Potassium (plasma)

    Time frame: change from baseline after 16 weeks

    Potassium (mmol/l)

  43. Iron (plasma)

    Time frame: change from baseline after 4, 8, 12, 16 weeks

    Iron (µmol/l)

  44. Ferritin (plasma)

    Time frame: change from baseline after 4, 8, 12, 16 weeks

    Ferritin (µg/l)

  45. Transferrin (plasma)

    Time frame: change from baseline after 4, 8, 12, 16 weeks

    Transferrin (g/l)

  46. Iodine (serum)

    Time frame: change from baseline after 16 weeks

    Iodine (µmol/l)

  47. Selenium (serum)

    Time frame: change from baseline after 16 weeks

    Selenium (µmol/l)

  48. Zinc (serum)

    Time frame: change from baseline after 16 weeks

    Zinc (µmol/l)

Other outcomes

  1. Creatinine (24 h urine)

    Time frame: change from baseline after 16 weeks

    Creatinine (mmol/l)

  2. Albumine (24 h urine)

    Time frame: change from baseline after 16 weeks

    Albumine (mg/l)

  3. Selenium (24 h urine)

    Time frame: change from baseline after 16 weeks

    Selenium (µmol/24 h)

  4. Zinc (24 h urine)

    Time frame: change from baseline after 16 weeks

    Zinc (µmol/24 h)

Sponsors and collaborators

Lead sponsor

University of Jena

Other

Registry information

Official study title

PrevA Study - Evaluation of an App-based Nutritional Concept to Lower Cardiovascular Risk Factors (Focus: Weight Reduction)

Acronym: PrevA

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Jan 20, 2021
Registry last updated
Mar 3, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.